White House Drops Heidi Overton’s FDA Nomination

“We need to go in a new direction at FDA, and everybody fully supports Secretary Kennedy’s vision to Make America Healthy Again and get back to a more populist and common-sense approach to health in America,” a senior administration official told Axios late Tuesday.

The White House is dropping Dr. Heidi Overton’s nomination to lead the Food and Drug Administration, a White House official confirmed Tuesday, one day before the Senate Health Committee was scheduled to vote on whether to advance her nomination to the full Senate. Axios first reported the decision.

“FDA nominee Heidi Overton lacks the support on the Hill to move forward with her confirmation,” the senior administration official said.

White House Drops Trump's FDA Pick Heidi Overton Before Senate Vote — 360 News Live

Overton, a physician and deputy director of the White House Domestic Policy Council, was nominated by President Trump in August. To advance out of the 21-member Health, Education, Pensions and Labor Committee, she would have needed 11 votes, meaning she could not afford to lose a single Republican if all Democrats opposed her.

Republican doubts

The move followed weeks of doubts from key Republicans. Sen. Bill Cassidy of Louisiana, the committee’s chairman, had scheduled the vote for Wednesday morning despite struggling to convince wavering GOP members. Before her September confirmation hearing, Cassidy wrote on X that he had “strong concerns” about her nomination, saying her lack of managerial experience left her poorly prepared to lead the agency.

He also said he had “strong concerns” about Overton’s role in the administration’s efforts to change childhood vaccine recommendations, which he called “almost disqualifying.” In a post last week, Cassidy said he remained undecided.

Sen. Susan Collins of Maine told NBC News last week she was undecided and had “not taken a position,” saying she needed “to get some answers on various things.”

Sen. Lisa Murkowski of Alaska declined last week to say how she’d vote, and during the hearing criticized Overton for not taking a clear position on political pressure surrounding access to mifepristone. Several Republicans, including Murkowski and Sen. Josh Hawley of Missouri, would not say Tuesday how they planned to vote, according to The Washington Sun.

Outside pressure

Overton faced pressure campaigns on multiple fronts. Hawley had been under heavy pressure from Marjorie Dannenfelser, president of SBA Pro-Life America, to oppose Overton unless the administration promised to expedite a thorough review of the abortion pill mifepristone — promises that would have further repelled the panel’s two Republicans who support abortion rights, Murkowski and Collins.

Antiabortion forces had questioned Overton’s commitment to tightening prescribing rules for mifepristone, and she drew criticism from segments of the MAHA movement that saw her as siding with health and agriculture interests.

Heidi Overton
Photo: axios.com

Signs reading “Say no to Heidi Vaperton for FDA commissioner” appeared around Washington over the weekend, placed by a “private group of citizens who prefer to stay anonymous,” according to group spokesperson Jenny Kay.

Former White House health adviser Calley Means, a close ally of Health Secretary Robert F. Kennedy Jr., had castigated Overton in interviews, saying she helped advance vaping industry interests. Means told The Washington Sun on Tuesday he is not involved in the group behind the signs.

The FDA has been led by acting Commissioner Kyle Diamantas since Dr. Marty Makary resigned in May, in part over the administration’s decision to authorize several fruit-flavored vaping products. The agency is set to finish its safety review of mifepristone in March.

Republicans have only a narrow window to confirm dozens of Trump administration nominees before Democrats take over Congress next year, and without a clear pick, filling the FDA post before Republicans lose the majority could prove extremely difficult.

Photo of author

Entertainment Desk

Entertainment Desk at Archyde.

Chase Home Lending Hires Hundreds of Advisors as Mortgage Demand Falls

Xi Courts Allies with Tariff Cuts During Pacific Summits